Market Place
Sourcing Support
City of Hope Reports Promise of Novel Immunotherapy for CLL
10 Dec 2024 //
BUSINESSWIRE
City Of Hope Shares Cancer Research At ASH 2024
10 Dec 2024 //
BUSINESSWIRE
MaaT Pharma Treats First U.S. Patient at City of Hope for GVHD
05 Dec 2024 //
BUSINESSWIRE
Kairos Adds City of Hope to Phase 2 ENV105 Trial
03 Dec 2024 //
BUSINESSWIRE
City of Hope Reveals Data on Cancer Immunotherapies at ASH 2024
21 Nov 2024 //
BUSINESSWIRE
City of Hope Reveals Mushroom Supplement Prevents Prostate Cancer
12 Nov 2024 //
BUSINESSWIRE
City Of Hope Receives $20M Gift For Pancreatic Research
25 Sep 2024 //
BUSINESSWIRE
City Of Hope Reports Positive Results On Lymphoma Vaccine
19 Sep 2024 //
BUSINESSWIRE
City Of Hope`s John Carpten Named Top U.S. Healthcare Diversity Leader
12 Aug 2024 //
BUSINESSWIRE
City Of Hope And IFLI Announce $2M Follicular Lymphoma Research Program
30 Jul 2024 //
BUSINESSWIRE
City Of Hope And Mount Sinai Show New Combo Treatment For Insulin Cells
10 Jul 2024 //
BUSINESSWIRE
City of Hope Shows Gut Microbiome Change Benefits Metastatic Kidney Cancer
28 Jun 2024 //
BUSINESSWIRE
City Of Hope Investigational: Cancers Featured At Asco 2024
23 May 2024 //
BUSINESSWIRE
New Biomarkers Found to Predict Kidney Failure in Type 1 Diabetes Patients
22 May 2024 //
BUSINESSWIRE
City of Hope to Present New Research at the AACR Annual Meeting
12 Mar 2024 //
BUSINESSWIRE
CAR-T for brain cancer extends survival in phase 1 trial
12 Mar 2024 //
FIERCE BIOTECH
City of Hope Launches Mobile Cancer Prevention and Screening Program
26 Feb 2024 //
BUSINESSWIRE
City of Hope, TGen Researchers Develop Machine-Learning Tool
24 Jan 2024 //
BUSINESSWIRE
City of Hope appoints Kristin Higgins, M.D., as chief clinical office
23 Jan 2024 //
BUSINESSWIRE
City of Hope Research Reveals an Immune Cell That Can Attack Cancer
10 Jan 2024 //
BUSINESSWIRE
City of Hope Cancer Center, Children’s Oncology Group conduct largest trial
09 Jan 2024 //
BUSINESSWIRE
City of Hope presents pivotal clinical trial data at ASH conference on revumenib
12 Dec 2023 //
BUSINESSWIRE
City of Hope Scientists Present Promising New Research at Annual Meeting
11 Dec 2023 //
BUSINESSWIRE
City of Hope Doctors and Scientists Present Innovative Research
08 Dec 2023 //
BUSINESSWIRE
Fortress Subsidiary Helocyte Announces Option Agreement with City of Hope
16 Oct 2023 //
GLOBENEWSWIRE
City of Hope and TGen Research Reveals What Potentially Causes a Leukemia
11 Oct 2023 //
BUSINESSWIRE
CytoImmune and City of Hope Begin Dosing in PI Trial Evaluating NKCT
28 Jul 2022 //
BUSINESSWIRE
City of Hope Could Provide New Treatment Model for SARS-CoV-2 Patients
20 May 2022 //
BUSINESSWIRE
City of Hope and Imugene Announce First Patient Dosed in Phase 1 Trial
17 May 2022 //
BUSINESSWIRE
Lancet Journal: COH04S1 Produces Robust Ab and T Cells Against SARS-CoV-2
10 Mar 2022 //
BUSINESSWIRE
City of Hope, Osel Announce Live Biotherapeutic Product CBM588`s Efficacy
28 Feb 2022 //
BUSINESSWIRE
City of Hope awarded $4.9M from CIRM in stem cell biology, regenerative medicine
22 Feb 2022 //
BIOSPACE
Mustang Bio Announces City of Hope MB-105 Prostate Stem Cell Antigen CAR T Data
15 Feb 2022 //
GLOBENEWSWIRE
Ostentus Tx, City of Hope to Initiate Studies of Novel OST Natural Products
27 Jan 2022 //
BUSINESSWIRE
City of Hope Researchers Find Improved Treatment Options for Colorectal Cancer
14 Dec 2021 //
BUSINESSWIRE
Pivotal Study by City of Hope Shows First-in-Class Cancer Immunotherapy Results
11 Dec 2021 //
BUSINESSWIRE
City of Hope to Acquire Cancer Treatment Centers of America
08 Dec 2021 //
BUSINESSWIRE
City of Hope Opens Oncolytic Virus Clinical Trial in Advanced Breast Cancer
18 Nov 2021 //
BUSINESSWIRE
Novel `nanosized` drug carriers tamp down HIV in the brain
27 Sep 2021 //
FIERCEBIOTECH
City of Hope and Griffith University Use Novel Method to Block HIV in Mice
20 Sep 2021 //
BIOSPACE
City of Hope Trial to Test COH04S1 Vaccine in Patients With Blood Cancers
14 Sep 2021 //
BUSINESSWIRE
City of Hope names 5 new board members
09 Sep 2021 //
BUSINESSWIRE
Calidi Biotherapeutics Announces Exclusive License Agreement with City of Hope
16 Aug 2021 //
BUSINESSWIRE
HepaRegeniX initiates first-in-man Ph1 trial for lead MKK4 inhibitor HRX 0215
10 Aug 2021 //
PIPELINEREVIEW
HepaRegeniX initiates first-in-man Ph1 trial for lead MKK4 inhibitor HRX 0215
10 Aug 2021 //
PIPELINEREVIEW
Update on new clinical Phase Ib trial for the RH5.1 blood-stage malaria vaccine
21 Jul 2021 //
CISION
Samsung Bioepis Initiates Phase 3 Clinical Trial for SB17
19 Jul 2021 //
PIPELINEREVIEW
City of Hope and Osel Announce Exclusive License for IP rights for CBM588
14 Jul 2021 //
BUSINESS WIRE
City of Hope and Osel Announce Exclusive License for IP rights for CBM588
14 Jul 2021 //
BUSINESS WIRE
City of Hope Identifies How Most Common Type of Breast Cancer Becomes resistant
26 Jun 2021 //
BUSINESSWIRE
City of Hope-led study details new strategy to address the barriers
01 Oct 2020 //
BUSINESSWIRE
City of Hope Distinguished Scientist Debbie Thurmond Named New Director Diabetes
30 Sep 2020 //
BUSINESSWIRE
